Splenic infarction medical therapy

Jump to: navigation, search

Splenic infarction Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Splenic Infarction from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Splenic infarction medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Splenic infarction medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Splenic infarction medical therapy

CDC on Splenic infarction medical therapy

Splenic infarction medical therapy in the news

Blogs on Splenic infarction medical therapy

Directions to Hospitals Treating Splenic infarction

Risk calculators and risk factors for Splenic infarction medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

There is no specific treatment, except treating the underlying disorder and providing adequate pain relief. Splenectomy is only required if complications ensue; surgical removal predisposes to overwhelming post-splenectomy infections.[1]

Medical Therapy

Surgery is indicated only in the presence of complications. Otherwise, the infarcted spleen can be left in situ, and the patient is observed. Due to the rarity of this disorder and the largely anecdotal character of many reports, the roles of antibiotics and antiplatelet agents (for the treatment of thrombocytosis) have not been formally addressed. Similarly, no scientifically supported information exists regarding the possible increase in susceptibility to overwhelming postsplenectomy sepsis in these patients.

The principal mainstay of medical therapy is analgesia with either narcotics or nonsteroidal anti-inflammatory agents.

In one series of 59 patients, mortality amounted to 5%.[2] Complications include a ruptured spleen, hemorrhage, splenic abscess (for example, if the underlying cause is endocarditis) or pseudocyst formation. Splenectomy may be warranted for persistent pseudocysts due to the high risk of subsequent rupture.[3]

References

  1. Salvi PF, Stagnitti F, Mongardini M, Schillaci F, Stagnitti A, Chirletti P (2007). "Splenic infarction, rare cause of acute abdomen, only seldom requires splenectomy. Case report and literature review". Ann Ital Chir. 78 (6): 529–32. PMID 18510036.
  2. Nores M, Phillips EH, Morgenstern L, Hiatt JR (1998). "The clinical spectrum of splenic infarction". Am Surg. 64 (2): 182–8. PMID 9486895. Unknown parameter |month= ignored (help)
  3. Pachter HL, Hofstetter SR, Elkowitz A, Harris L, Liang HG (1993). "Traumatic cysts of the spleen--the role of cystectomy and splenic preservation: experience with seven consecutive patients". J Trauma. 35 (3): 430–6. PMID 8371303. Unknown parameter |month= ignored (help)

Linked-in.jpg